Interstate Cigar Co., Inc. v. Sterling Drug Inc.

655 F.2d 29, 1981 U.S. App. LEXIS 11173
CourtCourt of Appeals for the Second Circuit
DecidedJuly 21, 1981
Docket909
StatusPublished
Cited by1 cases

This text of 655 F.2d 29 (Interstate Cigar Co., Inc. v. Sterling Drug Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Second Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Interstate Cigar Co., Inc. v. Sterling Drug Inc., 655 F.2d 29, 1981 U.S. App. LEXIS 11173 (2d Cir. 1981).

Opinion

655 F.2d 29

1981-2 Trade Cases 64,232

INTERSTATE CIGAR CO., INC., L.S. Amster & Co., Inc., and
Ladrew Distributors, Inc., Plaintiffs-Appellants,
v.
STERLING DRUG INC., Breon Laboratories Inc., Winthrop
Laboratories, Lehn& Fink, "John Doe No. 1," "John Doe No.
2," and "John Doe No. 3," names of last three defendants
being fictitious, true names of persons intended being
unknown, Defendants-Appellees.

Nos. 829, 909, Dockets 80-7631, 80-7633.

United States Court of Appeals,
Second Circuit.

Argued May 28, 1981.
Decided July 21, 1981.

Noel W. Hauser, P.C., New York City, for plaintiffs-appellants.

Frederick A. Nicoll, New York City (James B. Swire, David S. Robbins, Rogers Hoge & Hills, New York City, of counsel), for defendants-appellees.

Before FEINBERG, Chief Judge, and LUMBARD and MANSFIELD, Circuit Judges.

MANSFIELD, Circuit Judge:

Plaintiffs, distributors of over-the-counter medicine and health products, appeal from a judgment of the Southern District of New York entered by Judge Constance Baker Motley after a non-jury trial dismissing their damages claim based on the allegation that defendant drug manufacturers had engaged in price discrimination in violation of the Robinson-Patman Act, 15 U.S.C. § 13(a), by selling Haley's M-O ("M-O"), a drug product, to competing distributors at a 25% discount not given to plaintiffs, and awarding defendants $262,661.51 plus interest on their counterclaims for the price of M-O sold and delivered to plaintiffs. Plaintiffs also appeal from a judgment of the same court, entered after a jury verdict awarding them $75,000 damages for breach of an agreement by defendants to accept return of purchased M-O, granting defendants' post-trial motion for judgment notwithstanding the verdict and dismissing plaintiffs' breach of contract claim. Lastly, plaintiffs appeal two orders granting defendants reasonable attorneys' fees and costs in the sum of $1,000 based on plaintiffs' bad faith opposition to a reasonable protective order and interposition of a frivolous motion. We affirm the judgments and orders.

In March, 1977, plaintiffs bought various sizes of M-O from Glenbrook Laboratories Division of defendant Sterling Drug Inc. Beginning on April 1, 1977, Sterling, through its subsidiary Breon Laboratories, Inc., began marketing M-O at a 25% discount to customers which had not previously purchased or stocked M-O in any of its sizes within the preceding year. Between May and December, 1977, plaintiffs bought large quantities of M-O from defendants but did not receive the new customer 25% discount. Upon learning of this discount plaintiffs demanded the same discount on their purchases, which was refused on the ground that plaintiffs, not being new distributors of M-O, were ineligible to receive the discount. Defendants, however, did agree to accept the return of plaintiffs' 16-ounce size M-O remaining in stock, which plaintiffs had purchased from them. Subsequently, however, they refused to accept return of the goods. Plaintiffs claim that defendants violated § 2(a) of the Robinson-Patman Act by granting the 25% discount to other distributors but not to plaintiffs and § 2(e) of the Act by allowing other distributors to return purchases of M-O for full refund but refusing such privilege to plaintiffs.

Plaintiffs' § 2(a) Robinson-Patman Act price discrimination claim fails for two reasons. First, they did not show that the new distributor discount would tend to lessen competition substantially or to create a monopoly in any line of commerce, which is an essential condition precedent to establishing such a claim. See FLM Collission Parts, Inc. v. Ford Motor Co., 543 F.2d 1019 (2d Cir. 1976). Indeed, the discount offered to new distributors may well have increased competition by inducing newcomers to enter the M-O distribution field. Secondly, plaintiffs failed to introduce substantial evidence showing that they were actually injured by defendants' new distributor discount policy. Plaintiffs' theory, that they were entitled to "automatic damages," has been rejected by the Supreme Court, which requires a plaintiff to make a showing of actual injury attributable to a violation of the Robinson-Patman Act. J. Truett Payne Co. v. Chrysler Motors Corp., --- U.S. ----, ----, 101 S.Ct. 1923, 1927, 68 L.Ed.2d 442 (1981). See also Enterprise Industries, Inc. v. Texas Co., 240 F.2d 457 (2d Cir.), cert. denied, 353 U.S. 965, 77 S.Ct. 1049, 1 L.Ed.2d 914 (1957). For the latter reason, the dismissal of plaintiffs' § 2(e) claim must also be affirmed. Our affirmance of the dismissal of plaintiffs' Robinson-Patman Act claims should not be construed as an approval of the other grounds stated by Judge Motley in support of the dismissal.

With respect to plaintiffs' claim for rescission of their contract for purchase of M-O the jury, in response to special interrogatories, found that plaintiffs had failed to prove their allegations of fraud and misrepresentation, which formed the basis of their rescission claim. This verdict is supported by the record. The jury also found that defendants had breached their alleged contract to accept return of M-O in stock purchased from defendants, for which plaintiffs sought damages in the form of interest upon a line of credit used to finance their retention of the unreturned M-O and storage costs. Plaintiffs' claim that this finding entitled them to an order directing defendants to accept return of the merchandise must be denied because they sought rescission only on grounds of fraud and misrepresentation, which were rejected by the jury, and did not seek specific performance, to which they would not in any event be entitled, since any injury was compensable through money damages. Plaintiffs' sole remedy was damages based on interest charges incurred by them during the period when defendants were alleged to have improperly refused to accept the return of unsold M-O. For this the jury awarded $75,000. Judge Motley granted judgment n. o. v. on the ground that plaintiffs had failed to present the jury with sufficient evidence to justify a reasonable calculation of plaintiffs' interest costs. With this disposition we agree.

It is doubtful whether plaintiffs would be entitled to recover as damages interest charges incurred by them prior to liquidation of the amount owed, see 5 Corbin on Contracts § 1046 (1964 ed.); 1 Restatement of the Law of Contracts § 337, much less interest charges actually incurred by them (in this case claimed at 16% to 20% per annum) as distinguished from the legal or statutory rate, see Avalon Construction Corp. v. Kirch Holding Co., 256 N.Y. 137, 141, 175 N.E. 651 (1931); Rachlin & Co. v. Tra-Mar, Inc., 33 A.D.2d 370, 308 N.Y.S.2d 153 (1st Dep't 1970); Lee v. Joseph E. Seagram & Sons, Inc., 592 F.2d 39 (2d Cir. 1979); N.Y.C.P.L.R. §§ 5001(a), 5004. However, we need not resolve these issues in this case.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

En Vogue v. UK Optical Ltd.
843 F. Supp. 838 (E.D. New York, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
655 F.2d 29, 1981 U.S. App. LEXIS 11173, Counsel Stack Legal Research, https://law.counselstack.com/opinion/interstate-cigar-co-inc-v-sterling-drug-inc-ca2-1981.